Vor Ort
Merkzettel Warenkorb
Produktbild: Bile Acid Biology and Its Therapeutic Implications: Proceedings of the Falk Symposium 141 (XVIII Internationale Bile Acid Meeting) Held in Stockholm,
Band 141

Bile Acid Biology and Its Therapeutic Implications: Proceedings of the Falk Symposium 141 (XVIII Internationale Bile Acid Meeting) Held in Stockholm,

Aus der Reihe Falk Symposium

303,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

01.04.2005

Abbildungen

XV, 270 p.

Herausgeber

G. Paumgartner + weitere

Verlag

Springer Netherland

Seitenzahl

276

Maße (L/B/H)

23,4/15,6/1,8 cm

Gewicht

590 g

Auflage

2005

Sprache

Englisch

ISBN

978-1-4020-2893-9

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

01.04.2005

Abbildungen

XV, 270 p.

Herausgeber

Verlag

Springer Netherland

Seitenzahl

276

Maße (L/B/H)

23,4/15,6/1,8 cm

Gewicht

590 g

Auflage

2005

Sprache

Englisch

ISBN

978-1-4020-2893-9

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Bile Acid Biology and Its Therapeutic Implications: Proceedings of the Falk Symposium 141 (XVIII Internationale Bile Acid Meeting) Held in Stockholm,
  • List of principal contributors. List of chairpersons. Preface. Presentation of the Adolf Windaus Prize 2004; G. Paumgartner. Adolf Windaus Prize Lecture; K.D.R. Setchell.
    Section I: Synthesis And Metabolism Of Bile Acids.
    1 Multifunctional roles of bile acid biosynthetic enzymes and the isolation of a new vitamin D 25-hydroxylase; D.W. Russell, J.B. Cheng. 2 Studies on biosynthetic pathways to bile acids in human liver cells; M. Axelson, B. Mörk, K. Garmark, J. Shoda, G.T. Everson, J. Sjövall. 3 Role of CYP3A4 as a cholesterol and bile acid metabolizing enzyme; K. Bodin, U. Diczfalusy. 4 New insights into bile acid amidation; M.C. Hunt, E. O'Shea, K. Solaas, B. Frode Kase, S.E.H. Alexson. 5 Mechanisms of bile acid inhibition of bile acid synthesis; J.Y.L. Chiang, T. Li, B. Spalding-Yoder, S. Del Signore. 6 The farnesoid X receptor controls gene expression in a ligand-and promoter-selective fashion; J. Cui, J.-L. Lew, A. Zhao, L. Huang, S.D. Wright. 7 Regulation of bile acid biosynthesis by cell signalling pathways; P.B. Hylemon, S. Gupta, R. Natarajan, P. Dent. 8 Feedback regulation of human bile acid synthesis; E.C.S. Ellis, M. Axelson, A. Abrahamsson, G. Eggertsen, B.-G. Ericzon, I. Björkhem, C.A. Einarsson. 9 On the role of oxysterols in regulation of cholesterol homeostasis by nuclear receptors; S. Meaney, I. Björkhem.
    Section II: Transport Of Bile Acids And Lipids.
    10 Bile acid transport in Spgp (Bsep) knockout mice; P. Lam, R. Wang, V. Ling. 11 Bile salt and glutathione coefflux mediated by multidrug resistance protein MRP4 (ABCC4), a basolateral transporter of the hepatocyte; M. Rius, A.T. Nies, A.F. Hofmann, D. Keppler. 12 The role of farnesoid X receptor in regulating bile salt transport and synthesis; J.J. Eloranta, G.A. Kullak-Ublick. 13 Gender-specific expression of liver organic anion transporters; D. Rost, K. Kopplow, S. Gehrke, A. Stiehl, D. Mayer. 14 Molecular mechanisms of intestinal bile acid transport; A.L. Craddock, J.H.Haywood, M.L. Hubbert, P.A. Dawson. 15 Adaptive regulation of bile salt transporters in cholestasis - the role of MRP; W.S. Chen, A. Bohan, G. Denk, C. Soroka, L. Denson, J.L. Boyer. 16 Adaptive hepatobiliary transporter regulation by ursodeoxycholic acid; M. Trauner, P. Fickert, E. Halilbasic, M. Wagner, G. Zollner. 17 Molecular mechanism of biliary lipid secretion; A.K. Groen, R.P.J. Oude Elferink. 18 Haplotype analysis of hepatobiliary ABC transporter genes in cholecystolithiasis; F. Lammert, H.E. Wasmuth, R. Schirin-Sokhan, N. Rhabar-Tabrizi, H.-U. Marschall, S. Matern. 19 Molecular elucidation of intestinal cholesterol absorption; W. Kramer, F. Girbig, D. Corsiero, A. Pfenninger, W. Frick, G. Jähne.
    Section III: Biological And Pharmacological Effects Of Bile Acids.
    20 Actions of the bile acid receptor FXR; S. Kliewer. 21 Activation of MRP2 transport by ursodeoxycholic acid and its amidates; M. Vore, P. Gerk. 22 Role of mitogen-activated protein kinases in tauroursodeoxycholic acid-induced bile secretion in cholestatic rat liver; S. Hohenester, G.U. Denk, R. Wimmer, C. Rust, U. Beuers. 23 Bile acids and CD95 activation; D. Häussinger, A. Höngen, S. Becker, R. Reinehr. 24 Tauroursodeoxycholic acid, a bile acid with in-vivo antiapoptotic and
    neuroprotective properties; C.M.P. Rodrigues, C.J. Steer.
    Section IV: Bile Acids As Therapeutic Agents.
    25 Clinical presentation and treatment of familial unconjugated hypercholanaemia; A.K. Batta, G. Salen, D.H. Morton, V.E.H. Carlton, L.N. Bull, B.L. Shneider. 26 Comprehensive study of the effects of rifampicin and ursodeoxycholic acid on genes and proteins involved in regulation, transport and detoxification of biliary compounds in gallstone patients; H.-U. Marschall, M. Wagner, G. Zollner, P. Fickert, J. Gumhold, D. Silbert, U. Diczfalusy, L. Benthin, R. Grundström, U. Gustafsson, S. Sahlin, C. Einarsson, M. Trauner. 27 Dose effect of ursodeoxycholic acid used in the treatment of primary